These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1823905)

  • 1. Clinical and immunologic observations in patients with AIDS-related complex treated with IMREG-1.
    Gottlieb AA
    Int J Immunopharmacol; 1991; 13 Suppl 1():29-32. PubMed ID: 1823905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to treatment with the leukocyte-derived immunomodulator IMREG-1 in immunocompromised patients with AIDS-related complex. A multicenter, double-blind, placebo-controlled trial.
    Gottlieb MS; Zackin RA; Fiala M; Henry DH; Marcel AJ; Combs KL; Vieira J; Liebman HA; Cone LA; Hillman KS
    Ann Intern Med; 1991 Jul; 115(2):84-91. PubMed ID: 1676251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical benefits and recovery of delayed-type hypersensitivity in patients with AIDS-related complex treated with IMREG-1 or placebo.
    Fiala M; Cone LA; Sayre JW
    Int J Immunopharmacol; 1991; 13(7):999-1004. PubMed ID: 1761364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of immunomodulators for treatment of HIV infection.
    Gottlieb AA; Gottlieb MS
    Lymphology; 1990 Jun; 23(2):98-101. PubMed ID: 2214868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel methodology for quantitating the enhancement of cutaneous delayed-type hypersensitivity by IMREG-1: a measure of the immunopotentiation of cell-mediated immunity.
    Sizemore RC; Kern CH; Gottlieb MS; Gottlieb AA
    Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 1):308-13. PubMed ID: 7554453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstitution of immune function in AIDS/ARC.
    Gottlieb AA; Gottlieb MS; Scholes VE
    Concepts Immunopathol; 1987; 4():261-74. PubMed ID: 2954644
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunostimulation in the lymphadenopathy syndrome and in AIDS--Inosiplex (inosin pranobex, methisoprinol].
    Grossmann D; Behrens MI
    Onkologie; 1987 Jun; 10(3 Suppl):12-6. PubMed ID: 2443884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017).
    Mulder JW; Cooper DA; Mathiesen L; Sandström E; Clumeck N; Gatell JM; French M; Donovan B; Gray F; Yeo JM
    AIDS; 1994 Mar; 8(3):313-21. PubMed ID: 7913326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex.
    Pedersen C; Cooper DA; Brun-Vézinet F; Doherty R; Skinhøj P; Pérol Y; Lüthy R; Leibowitch J; Habermehl KO; Varnier OE
    AIDS; 1992 Aug; 6(8):821-5. PubMed ID: 1418778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic changes in monocytes and alveolar macrophages in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC).
    Roy G; Rojo N; Leyva-Cobián F
    J Clin Lab Immunol; 1987 Jul; 23(3):135-41. PubMed ID: 3118038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I/II trial of recombinant interleukin-2 in AIDS/ARC: alterations of phenotypes of peripheral blood mononuclear cells.
    Flad HD; Ernst M; Kern P
    Lymphokine Res; 1986; 5 Suppl 1():S171-6. PubMed ID: 3491258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virological examinations of patients with AIDS-related complex/Walter-Reed 5 enrolled in a double-blind placebo-controlled study with intravenous gammaglobulin administration. Prognostic value of anti-p24 determination. The ARC-IVIG Study Group.
    Mertens T; Ramon A; Kruppenbacher JP; Heitmann K; Pika U; Leyssens N; Lievens M
    Vox Sang; 1990; 59 Suppl 1():21-9. PubMed ID: 1700551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant alpha-2a interferon treatment in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC): clinical and immunological evaluation.
    Mezzaroma I; Avella A; Paganelli R; Ensoli B; d'Offizi G; Sirianni MC; Luzi G; Valdarchi C; Aiuti F
    Allergol Immunopathol (Madr); 1991; 19(5):201-7. PubMed ID: 1811417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, placebo-controlled trial of thymostimulin in symptomatic HIV-infected patients.
    Beall G; Kruger S; Morales F; Imagawa D; Goldsmith JA; Fisher D; Steinberg J; Phair J; Whaling S; Bitran J
    AIDS; 1990 Jul; 4(7):679-81. PubMed ID: 1975746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose intravenous immunoglobulins in HIV-1-infected adults with AIDS-related complex and Walter-Reed 5.
    Schrappe-Bächer M; Rasokat H; Bauer P; Bendick C; Bube FW; Degenhardt S; Fätkenheuer G; Heiniger HJ; Heitmann K; Imbach P
    Vox Sang; 1990; 59 Suppl 1():3-14. PubMed ID: 1978443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement levels and circulating immune complexes in a controlled, longitudinal, multicentre study on effects of intravenous immunoglobulin in adults with AIDS-related complex/Walter-Reed 5. The ARC-IVIG Study Group.
    Späth PJ; Braun M; Meyer-Hänni L; Mohren D; Mauff G
    Vox Sang; 1990; 59 Suppl 1():51-8. PubMed ID: 2238575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome.
    Karpas A; Hill F; Youle M; Cullen V; Gray J; Byron N; Hayhoe F; Tenant-Flowers M; Howard L; Gilgen D
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9234-7. PubMed ID: 3194422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind randomized trial. European-Australian Collaborative Group.
    Cooper DA; Pehrson PO; Pedersen C; Moroni M; Oksenhendler E; Rozenbaum W; Clumeck N; Faber V; Stille W; Hirschel B
    AIDS; 1993 Feb; 7(2):197-207. PubMed ID: 8096703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
    Fischl MA; Richman DD; Hansen N; Collier AC; Carey JT; Para MF; Hardy WD; Dolin R; Powderly WG; Allan JD
    Ann Intern Med; 1990 May; 112(10):727-37. PubMed ID: 1970466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of immunoglobulin preparation on course of AIDS-related complex (ARC).
    Ohno T; Kanoh T; Uchino H; Harada S
    Tohoku J Exp Med; 1988 Dec; 156(4):415-6. PubMed ID: 3266686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.